Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Sleep Is Compromised in -12° Head Down Tilt Position.

Boschert AL, Elmenhorst D, Gauger P, Li Z, Garcia-Gutierrez MT, Gerlach D, Johannes B, Zange J, Bauer A, Rittweger J.

Front Physiol. 2019 Apr 16;10:397. doi: 10.3389/fphys.2019.00397. eCollection 2019.

2.

Phosphocreatine Levels in the Left Thalamus Decline during Wakefulness and Increase after a Nap.

Gordji-Nejad A, Matusch A, Li S, Kroll T, Beer S, Elmenhorst D, Bauer A.

J Neurosci. 2018 Dec 5;38(49):10552-10565. doi: 10.1523/JNEUROSCI.0865-18.2018. Epub 2018 Oct 3.

3.

Cognitive impairments by alcohol and sleep deprivation indicate trait characteristics and a potential role for adenosine A1 receptors.

Elmenhorst EM, Elmenhorst D, Benderoth S, Kroll T, Bauer A, Aeschbach D.

Proc Natl Acad Sci U S A. 2018 Jul 31;115(31):8009-8014. doi: 10.1073/pnas.1803770115. Epub 2018 Jul 16.

4.

Reestablishment of individual sleep structure during a single 14-h recovery sleep episode after 58 h of wakefulness.

Hennecke E, Elmenhorst D, Mendolia F, Putzke M, Bauer A, Aeschbach D, Elmenhorst EM.

J Sleep Res. 2019 Jun;28(3):e12641. doi: 10.1111/jsr.12641. Epub 2017 Nov 24.

PMID:
29171170
5.

Effects of Long-Term Caffeine Consumption on the Adenosine A1 Receptor in the Rat Brain: an In Vivo PET Study with [18F]CPFPX.

Nabbi-Schroeter D, Elmenhorst D, Oskamp A, Laskowski S, Bauer A, Kroll T.

Mol Imaging Biol. 2018 Apr;20(2):284-291. doi: 10.1007/s11307-017-1116-4.

PMID:
28895043
6.

Neurotransmitter receptor availability in the rat brain is constant in a 24 hour-period.

Oskamp A, Wedekind F, Kroll T, Elmenhorst D, Bauer A.

Chronobiol Int. 2017;34(7):866-875. doi: 10.1080/07420528.2017.1325370. Epub 2017 May 26.

PMID:
28548869
7.

Recovery sleep after extended wakefulness restores elevated A1 adenosine receptor availability in the human brain.

Elmenhorst D, Elmenhorst EM, Hennecke E, Kroll T, Matusch A, Aeschbach D, Bauer A.

Proc Natl Acad Sci U S A. 2017 Apr 18;114(16):4243-4248. doi: 10.1073/pnas.1614677114. Epub 2017 Apr 3.

8.

Circadian variation of metabotropic glutamate receptor 5 availability in the rat brain.

Elmenhorst D, Mertens K, Kroll T, Oskamp A, Ermert J, Elmenhorst EM, Wedekind F, Beer S, Coenen HH, Bauer A.

J Sleep Res. 2016 Dec;25(6):754-761. doi: 10.1111/jsr.12432. Epub 2016 Jun 30.

9.

Chronic sleep restriction induces long-lasting changes in adenosine and noradrenaline receptor density in the rat brain.

Kim Y, Elmenhorst D, Weisshaupt A, Wedekind F, Kroll T, McCarley RW, Strecker RE, Bauer A.

J Sleep Res. 2015 Oct;24(5):549-558. doi: 10.1111/jsr.12300. Epub 2015 Apr 21.

10.

Association of adenosine receptor gene polymorphisms and in vivo adenosine A1 receptor binding in the human brain.

Hohoff C, Garibotto V, Elmenhorst D, Baffa A, Kroll T, Hoffmann A, Schwarte K, Zhang W, Arolt V, Deckert J, Bauer A.

Neuropsychopharmacology. 2014 Dec;39(13):2989-99. doi: 10.1038/npp.2014.150. Epub 2014 Jun 19.

11.

Reproducibility of non-invasive a1 adenosine receptor quantification in the rat brain using [(18)F]CPFPX and positron emission tomography.

Kroll T, Elmenhorst D, Weisshaupt A, Beer S, Bauer A.

Mol Imaging Biol. 2014 Oct;16(5):699-709. doi: 10.1007/s11307-014-0729-0.

PMID:
24595700
12.

Cross sectional PET study of cerebral adenosine A₁ receptors in premanifest and manifest Huntington's disease.

Matusch A, Saft C, Elmenhorst D, Kraus PH, Gold R, Hartung HP, Bauer A.

Eur J Nucl Med Mol Imaging. 2014 Jun;41(6):1210-20. doi: 10.1007/s00259-014-2724-8. Epub 2014 Feb 25.

PMID:
24566949
13.

Oxytocin enhances attractiveness of unfamiliar female faces independent of the dopamine reward system.

Striepens N, Matusch A, Kendrick KM, Mihov Y, Elmenhorst D, Becker B, Lang M, Coenen HH, Maier W, Hurlemann R, Bauer A.

Psychoneuroendocrinology. 2014 Jan;39:74-87. doi: 10.1016/j.psyneuen.2013.09.026. Epub 2013 Oct 5.

PMID:
24275006
14.

[¹⁸F]Altanserin and small animal PET: impact of multidrug efflux transporters on ligand brain uptake and subsequent quantification of 5-HT₂A receptor densities in the rat brain.

Kroll T, Elmenhorst D, Matusch A, Celik AA, Wedekind F, Weisshaupt A, Beer S, Bauer A.

Nucl Med Biol. 2014 Jan;41(1):1-9. doi: 10.1016/j.nucmedbio.2013.09.001. Epub 2013 Oct 9.

PMID:
24120220
15.

In vivo kinetic and steady-state quantification of 18F-CPFPX binding to rat cerebral A1 adenosine receptors: validation by displacement and autoradiographic experiments.

Elmenhorst D, Kroll T, Wedekind F, Weisshaupt A, Beer S, Bauer A.

J Nucl Med. 2013 Aug;54(8):1411-9. doi: 10.2967/jnumed.112.115576. Epub 2013 Jun 5.

16.

Suitability of [18F]altanserin and PET to determine 5-HT2A receptor availability in the rat brain: in vivo and in vitro validation of invasive and non-invasive kinetic models.

Kroll T, Elmenhorst D, Matusch A, Wedekind F, Weisshaupt A, Beer S, Bauer A.

Mol Imaging Biol. 2013 Aug;15(4):456-67. doi: 10.1007/s11307-013-0621-3. Epub 2013 Mar 1.

PMID:
23456885
17.

Sleep deprivation increases cerebral serotonin 2A receptor binding in humans.

Elmenhorst D, Kroll T, Matusch A, Bauer A.

Sleep. 2012 Dec 1;35(12):1615-23. doi: 10.5665/sleep.2230.

18.

Caffeine occupancy of human cerebral A1 adenosine receptors: in vivo quantification with 18F-CPFPX and PET.

Elmenhorst D, Meyer PT, Matusch A, Winz OH, Bauer A.

J Nucl Med. 2012 Nov;53(11):1723-9. doi: 10.2967/jnumed.112.105114. Epub 2012 Sep 10.

19.

Test-retest stability of cerebral mGluR₅ quantification using [¹¹C]ABP688 and positron emission tomography in rats.

Elmenhorst D, Aliaga A, Bauer A, Rosa-Neto P.

Synapse. 2012 Jun;66(6):552-60. doi: 10.1002/syn.21542. Epub 2012 Mar 16.

PMID:
22290765
20.

Adenosine A(1) receptors in human brain and transfected CHO cells: Inhibition of [(3)H]CPFPX binding by adenosine and caffeine.

Elmenhorst D, Garibotto V, Prescher A, Bauer A.

Neurosci Lett. 2011 Jan 10;487(3):415-20. doi: 10.1016/j.neulet.2010.10.068. Epub 2010 Nov 4.

PMID:
21056087
21.

In vivo and in vitro validation of reference tissue models for the mGluR(5) ligand [(11)C]ABP688.

Elmenhorst D, Minuzzi L, Aliaga A, Rowley J, Massarweh G, Diksic M, Bauer A, Rosa-Neto P.

J Cereb Blood Flow Metab. 2010 Aug;30(8):1538-49. doi: 10.1038/jcbfm.2010.65. Epub 2010 Jun 9.

22.

Effects of nocturnal aircraft noise on cognitive performance in the following morning: dose-response relationships in laboratory and field.

Elmenhorst EM, Elmenhorst D, Wenzel J, Quehl J, Mueller U, Maass H, Vejvoda M, Basner M.

Int Arch Occup Environ Health. 2010 Oct;83(7):743-51. doi: 10.1007/s00420-010-0515-5. Epub 2010 Feb 9.

PMID:
20143082
23.

Nigrostriatal upregulation of 5-HT2A receptors correlates with motor dysfunction in progressive supranuclear palsy.

Stamelou M, Matusch A, Elmenhorst D, Hurlemann R, Eggert KM, Zilles K, Oertel WH, Höglinger GU, Bauer A.

Mov Disord. 2009 Jun 15;24(8):1170-5. doi: 10.1002/mds.22533.

PMID:
19353726
24.

Sleep deprivation increases A(1) adenosine receptor density in the rat brain.

Elmenhorst D, Basheer R, McCarley RW, Bauer A.

Brain Res. 2009 Mar 3;1258:53-8. doi: 10.1016/j.brainres.2008.12.056. Epub 2008 Dec 31.

25.

Mesolimbic functional magnetic resonance imaging activations during reward anticipation correlate with reward-related ventral striatal dopamine release.

Schott BH, Minuzzi L, Krebs RM, Elmenhorst D, Lang M, Winz OH, Seidenbecher CI, Coenen HH, Heinze HJ, Zilles K, Düzel E, Bauer A.

J Neurosci. 2008 Dec 24;28(52):14311-9. doi: 10.1523/JNEUROSCI.2058-08.2008.

26.

Biodistribution and radiation dosimetry of the A1 adenosine receptor ligand 18F-CPFPX determined from human whole-body PET.

Herzog H, Elmenhorst D, Winz O, Bauer A.

Eur J Nucl Med Mol Imaging. 2008 Aug;35(8):1499-506. doi: 10.1007/s00259-008-0753-x. Epub 2008 Mar 29.

PMID:
18373090
27.

Performance impairment during four days partial sleep deprivation compared with the acute effects of alcohol and hypoxia.

Elmenhorst D, Elmenhorst EM, Luks N, Maass H, Mueller EW, Vejvoda M, Wenzel J, Samel A.

Sleep Med. 2009 Feb;10(2):189-97. doi: 10.1016/j.sleep.2007.12.003. Epub 2008 Feb 13.

PMID:
18276188
28.

Sleep deprivation upregulates A1 adenosine receptors in the rat basal forebrain.

Basheer R, Bauer A, Elmenhorst D, Ramesh V, McCarley RW.

Neuroreport. 2007 Dec 3;18(18):1895-9.

PMID:
18007182
29.

Cerebral A1 adenosine receptors (A1AR) in liver cirrhosis.

Boy C, Meyer PT, Kircheis G, Holschbach MH, Herzog H, Elmenhorst D, Kaiser HJ, Coenen HH, Haussinger D, Zilles K, Bauer A.

Eur J Nucl Med Mol Imaging. 2008 Mar;35(3):589-97. Epub 2007 Nov 14.

PMID:
18000666
30.

Partial sleep deprivation: impact on the architecture and quality of sleep.

Elmenhorst EM, Elmenhorst D, Luks N, Maass H, Vejvoda M, Samel A.

Sleep Med. 2008 Dec;9(8):840-50. Epub 2007 Oct 24.

PMID:
17921066
31.

5-HT2A receptor density is decreased in the at-risk mental state.

Hurlemann R, Matusch A, Kuhn KU, Berning J, Elmenhorst D, Winz O, Kolsch H, Zilles K, Wagner M, Maier W, Bauer A.

Psychopharmacology (Berl). 2008 Jan;195(4):579-90. Epub 2007 Sep 27.

PMID:
17899021
32.

Acute S-ketamine application does not alter cerebral [18F]altanserin binding: a pilot PET study in humans.

Matusch A, Hurlemann R, Rota Kops E, Winz OH, Elmenhorst D, Herzog H, Zilles K, Bauer A.

J Neural Transm (Vienna). 2007;114(11):1433-42. Epub 2007 Jun 1.

PMID:
17541696
33.

Sleep deprivation increases A1 adenosine receptor binding in the human brain: a positron emission tomography study.

Elmenhorst D, Meyer PT, Winz OH, Matusch A, Ermert J, Coenen HH, Basheer R, Haas HL, Zilles K, Bauer A.

J Neurosci. 2007 Feb 28;27(9):2410-5.

34.

Test-retest stability of cerebral A1 adenosine receptor quantification using [18F]CPFPX and PET.

Elmenhorst D, Meyer PT, Matusch A, Winz OH, Zilles K, Bauer A.

Eur J Nucl Med Mol Imaging. 2007 Jul;34(7):1061-70. Epub 2007 Jan 23.

PMID:
17242921
35.

Metabolism of the A1 adenosine receptor PET ligand [18F]CPFPX by CYP1A2: implications for bolus/infusion PET studies.

Matusch A, Meyer PT, Bier D, Holschbach MH, Woitalla D, Elmenhorst D, Winz OH, Zilles K, Bauer A.

Nucl Med Biol. 2006 Oct;33(7):891-8.

PMID:
17045169
36.

Effect of aging on cerebral A1 adenosine receptors: A [18F]CPFPX PET study in humans.

Meyer PT, Elmenhorst D, Boy C, Winz O, Matusch A, Zilles K, Bauer A.

Neurobiol Aging. 2007 Dec;28(12):1914-24. Epub 2006 Sep 22.

PMID:
16996650
37.

A1 adenosine receptor PET using [18F]CPFPX: displacement studies in humans.

Meyer PT, Elmenhorst D, Matusch A, Winz O, Zilles K, Bauer A.

Neuroimage. 2006 Sep;32(3):1100-5. Epub 2006 Jun 27.

PMID:
16806981
38.

18F-CPFPX PET: on the generation of parametric images and the effect of scan duration.

Meyer PT, Elmenhorst D, Matusch A, Winz O, Zilles K, Bauer A.

J Nucl Med. 2006 Feb;47(2):200-7.

39.

Quantification of cerebral A1 adenosine receptors in humans using [18F]CPFPX and PET: an equilibrium approach.

Meyer PT, Elmenhorst D, Bier D, Holschbach MH, Matusch A, Coenen HH, Zilles K, Bauer A.

Neuroimage. 2005 Feb 15;24(4):1192-204. Epub 2004 Dec 10.

PMID:
15670697
40.

Supplemental Content

Loading ...
Support Center